Visilizumab (Anti-CD3)

Visilizumab (Anti-CD3) is a humanized, non-Fc receptor (FcR)-binding IgG2 monoclonal antibody (MoAb) directed against CD3 with potential immunosuppressive activity. Visilizumab has the potential to be used for ulcerative colitis and Crohn's disease research. MW : 144.62 KD.

• Supplier: Selleck Chemicals
• Product #: A2816
• Sku #: A2816-1mg